Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Renovaro Inc. - Common Stock (NQ: RENB )

0.6687 -0.0113 (-1.66%)
Streaming Delayed Price Updated: 9:38 AM EDT, Oct 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 86,538
Open 0.6941
Bid (Size) 0.6642 (3)
Ask (Size) 0.7000 (7)
Prev. Close 0.6800
Today's Range 0.6587 - 0.7145
52wk Range 0.3950 - 5.250
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
From Renovaro Inc
Via GlobeNewswire

Performance

YTD
-79.04%
-79.04%
1 Month
+28.60%
+28.60%
3 Month
-48.16%
-48.16%
6 Month
-68.90%
-68.90%
1 Year
-75.77%
-75.77%

More News

Read More
Powerful Leadership Transition to Optimize Highly Promising AI Platform, RenovaroCube for Multi-Cancer Early Detection and Patient Monitoring: Renovaro, Inc. (Nasdaq: RENB)
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence
Renovaro Announces Strategic Restructuring and Leadership Transition
From Renovaro Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics
From Renovaro Inc
Via GlobeNewswire
Specialist AI Team from “PersonalAIze” Highlights the Strength, Potential and Visionary Talent Behind Software as a Service (SaaS) Platform for Early Cancer Detection: Renovaro, Inc. (Nasdaq: RENB)
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence
Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
From Renovaro Inc
Via GlobeNewswire
RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress
From Renovaro Inc
Via GlobeNewswire
RenovaroCube Announces Strategic Offering of Up to 20% Ownership
From Renovaro Inc
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Renovaro, Inc. Announces $10 million in Equity Committed
From Renovaro Inc
Via GlobeNewswire
Impressive Short Squeeze Triggered for Cancer Immunotherapy Company Renovaro, Inc. (NASDAQ: RENB)
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
From Renovaro Inc
Via GlobeNewswire
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
Via FinancialNewsMedia
Topics Death
Exposures Death
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
From FN Media Group LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
RENB Stock Earnings: Renovaro Biosciences Reported Results for Q3 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.